R2	Has_temporal Arg1:T4 Arg2:T6	
R3	Has_temporal Arg1:T1 Arg2:T2	
*	OR T5 T8 T7
R1	AND Arg1:T4 Arg2:T5	
T1	Procedure 6 18	chemotherapy
T2	Temporal 0 5	Prior
T3	Line 0 18	Prior chemotherapy
T4	Procedure 25 34	treatment
T5	Drug 40 49	gefitinib
T6	Temporal 19 24	Prior
T8	Drug 51 60	erlotinib
T7	Drug 71 93	drugs that target EGFR
T10	Line 19 93	Prior treatment with gefitinib, erlotinib, or other drugs that target EGFR
T11	Post-eligibility 94 157	Patients must not be receiving any other investigational agents
T12	Condition 174 199	interstitial lung disease
